Gerrit-Anne Van Es

Showing 1-20 of 21 articles

Coronary interventions

A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial

Modolo R, Chichareon P, Kogame N, Asano T, Chang C, de Winter R, Kaul U, Zaman A, Spitzer E, Takahashi K, Katagiri Y, Soliman O, Van Es G-A, Morel M, Onuma Y, Serruys P

July 19, 2019 | 10.4244/EIJ-D-18-00499

Coronary interventions

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

Vranckx P, Valgimigli M, Windecker S, Steg P, Hamm C, Jüni P, Garcia-Garcia H, Van Es G-A, Serruys P

November 20, 2016 | 10.4244/EIJY15M11_07

Coronary interventions

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Kappetein AP, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G

September 18, 2016 | 10.4244/EIJV12I7A141

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein AP, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy

Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein AP, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P

December 27, 2013 | 10.4244/EIJV9I8A170

The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy

March 22, 2013 | 10.4244/EIJV8I11A196

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document

Kappetein AP, Head S, Généreux P, Piazza N, Van Mieghem N, Blackstone E, Brott T, Cohen D, Cutlip D, Van Es G-A, Hahn R, Kirtane A, Krucoff M, Kodali S, Mack M, Mehran R, Rodés-Cabau J, Vranckx P, Webb J, Windecker S, Serruys P, Leon M

November 20, 2012 | 10.4244/EIJV8I7A121

The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis

Van Mieghem N, Head S, van der Boon R, Piazza N, de Jaegere P, Carrel T, Kappetein AP, Lange R, Walther T, Windecker S, Van Es G-A, Serruys P

June 27, 2012 | 10.4244/EIJV8I2A40

The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)

Wykrzykowska J, Serruys P, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Van Es G-A, Jüni P, Windecker S

November 30, 2011 | 10.4244/EIJV7I7A125

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

Vranckx P, Boersma E, Garg S, Valgimigli M, Van Es G-A, Goedhart D, Serruys P

November 30, 2011 | 10.4244/EIJV7I7A134

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

Wykrzykowska J, Garg S, Onuma Y, de Vries T, Morel M, Van Es G-A, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice M, Di Mario C, van Geuns R, Jüni P, Windecker S, Serruys P

September 30, 2011 | 10.4244/EIJV7I5A97

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

Garg S, Wykrzykowska J, Serruys P, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Tyczynski P, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

March 21, 2011

Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study

Sarno G, Garg S, Gomez-Lara J, Garcia-Garcia H, Ligthart J, Bruining N, Onuma Y, Witberg K, van Geuns R, de Boer S, Wykrzykowska J, Schultz C, Duckers H, Regar E, de Jaegere P, de Feyter P, Van Es G-A, Boersma E, van der Giessen WJ, Serruys P

March 21, 2011

Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation

Piazza N, Nuis R, Tzikas A, Otten A, Onuma Y, Garcia-Garcia H, Schultz C, van Domburg R, Van Es G-A, van Geuns R, de Jaegere P, Serruys P

September 30, 2010

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

Garg S, Sarno G, Serruys P, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, van Geuns R, Eerdmans P, Van Es G-A, Meier B, Jüni P, Windecker S

June 30, 2010

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

van Domburg R, Daemen J, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Van Es G-A, Wittebols K, Macours N, Stoll H, Serruys P

April 12, 2010

Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting

Garcia-Garcia H, Mintz G, Lerman A, Vince G, Margolis PM, Van Es G-A, Morel M, Nair A, Virmani R, Burke A, Stone G, Serruys P

June 30, 2009

Assessment of the SYNTAX score in the Syntax study

Serruys P, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, van Dyck N, Mack M, Holmes D, Feldman T, Morice M, Colombo A, Bass E, Leadley K, Dawkins K, Van Es G-A, Morel M, Mohr F

May 19, 2009

Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis

de Jaegere P, Piazza N, Galema T, Otten A, Soliman O, Van Dalen B, Geleijnse M, Kappetein AP, Garcia-Garcia H, Van Es G-A, Serruys P

November 20, 2008

Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water

Vranckx P, Kint P-P, Morel M, Van Es G-A, Serruys P, Cutlip D

August 20, 2008

Latest news

NEW ISSUE

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

June 25, 2020

NEW

Ahead of print: EAPCI Core Curriculum for PCI (2020)

July 7, 2020

Editorial

IVUS guidance during left main PCI: not if, but when and how

Akiko Maehara

July 8, 2020

NEW

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

July 6, 2020

Editorial

Left main PCI: are we giving the kiss the attention it deserves?

July 8, 2020

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

July 1, 2020

JAA

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Gerrit-Anne Van Es

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke